Versatope awarded up to $17.9M to develop a universal influenza vaccine using extracellular bacterial vesicles

October 24, 2019 Leave a comment 1,054 Views

Versatope Therapeutics, Inc., a biotechnology company developing vaccines and therapeutics, announced today that it has been awarded a contract with National Institute of Allergy and Infectious...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: NIAID

Versatope awarded up to $17.9M to develop a universal influenza vaccine using extracellular bacterial vesicles

Identification of a novel RNA aptamer that selectively targets breast cancer exosomes

Capricor Therapeutics Announces Publication Demonstrating Methods for Enhanced Potency of Cardiosphere-Derived Exosomes

Functional single-cell profiling identifies that exosomes are associated with increased immune cell infiltration in non-metastatic breast cancer

Liquid biopsy-based exo-oncomiRNAs can predict prostate cancer aggressiveness

The body’s own signalling system provides the key to new diagnostic tools and personalized medicine

FT-IR spectroscopy to show alterations in molecular composition of EV subpopulations from melanoma cell lines in different malignancy